主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TENX
#2563
Tenax Therapeutics, Inc.
12.000
0
-0.41%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.41%
每月变动
-19.46%
6个月变化
+58.94%
年变化
+58.94%
前一天收盘价
12.050
0
Open
12.000
0
Bid
Ask
Low
12.000
0
High
12.000
0
交易量
13
市场
股票
医疗保健
TENX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
3.41 M
3.97 M
4.15 M
4.56 M
6.24 M
—
Valuation ratios
Enterprise value
11.3 M
-70.32 M
-84.23 M
-79.22 M
-51.89 M
-285.66 M
Price to earnings ratio
—
-5.38
—
—
2.52
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
6.39
—
—
9.41
—
Price to book ratio
—
1.03
—
—
0.54
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.04
-0.06
-0.09
-0.1
-0.15
-0.41
Return on equity %
0.04
-0.07
-0.1
-0.1
-0.16
-0.43
Return on invested capital %
—
-2.24
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
38.95
20.6
40.48
41.89
15.58
118.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.23
-0.19
-0.16
-0.24
-0.82
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.07
3.04
2.77
2.57
8.45
Net current asset value per share
—
6.33
3.06
2.78
2.66
14.83
Tangible book value per share
—
6.02
2.99
2.71
2.49
14.21
Working capital per share
—
6.02
2.99
2.71
2.49
14.21
Book value per share
—
6.02
2.99
2.71
2.49
14.21
新闻
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)
Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing
Tesla, Goldman Sachs among market cap stock movers on Monday
Tenax Therapeutics公司的第三期LEVEL研究确认招募目标
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target
古根海姆将Tenax Therapeutics目标价从14美元上调至25美元
Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim
Tenax Therapeutics董事Rich Stuart购入价值$50,792的股票
Tenax Therapeutics director Rich Stuart buys $50,792 in stock
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999
Tenax Therapeutics临时CFO McGauley购入价值58,164美元股票